BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 3698918)

  • 1. Evidence that a decrease in opioid tone may evoke preovulatory luteinizing hormone release in the rat.
    Allen LG; Kalra SP
    Endocrinology; 1986 Jun; 118(6):2375-81. PubMed ID: 3698918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence that a decrease in opioid tone on proestrus changes the episodic pattern of luteinizing hormone (LH) secretion: implications in the preovulatory LH hypersecretion.
    Allen LG; Hahn E; Caton D; Kalra SP
    Endocrinology; 1988 Mar; 122(3):1004-13. PubMed ID: 3125034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A decrease in opioid tone amplifies the luteinizing hormone surge in estrogen-treated ovariectomized rats: comparisons with progesterone effects.
    Masotto C; Sahu A; Dube MG; Kalra SP
    Endocrinology; 1990 Jan; 126(1):18-25. PubMed ID: 2293982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of endogenous opioid influence on luteinizing hormone secretion by progesterone and estrogen.
    Gabriel SM; Simpkins JW; Kalra SP
    Endocrinology; 1983 Nov; 113(5):1806-11. PubMed ID: 6313330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An opioid-neuropeptide-Y transmission line to luteinizing hormone (LH)-releasing hormone neurons: a role in the induction of LH surge.
    Sahu A; Crowley WR; Kalra SP
    Endocrinology; 1990 Feb; 126(2):876-83. PubMed ID: 2404749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disinhibition from opioid influence augments hypothalamic neuropeptide Y (NPY) gene expression and pituitary luteinizing hormone release: effects of NPY messenger ribonucleic acid antisense oligodeoxynucleotides.
    Xu B; Sahu A; Kalra PS; Crowley WR; Kalra SP
    Endocrinology; 1996 Jan; 137(1):78-84. PubMed ID: 8536645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in the pulsatile pattern of luteinizing hormone secretion during the rat estrous cycle.
    Fox SR; Smith MS
    Endocrinology; 1985 Apr; 116(4):1485-92. PubMed ID: 3882410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RU486 administration blocks neuropeptide Y potentiation of luteinizing hormone (LH)-releasing hormone-induced LH surges in proestrous rats.
    Bauer-Dantoin AC; Tabesh B; Norgle JR; Levine JE
    Endocrinology; 1993 Dec; 133(6):2418-23. PubMed ID: 8243259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endogenous opioid peptides mediate the interleukin-1-induced inhibition of the release of luteinizing hormone (LH)-releasing hormone and LH.
    Kalra PS; Fuentes M; Sahu A; Kalra SP
    Endocrinology; 1990 Nov; 127(5):2381-6. PubMed ID: 2226323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endogenous opioids mediate the nocturnal prolactin surge in the pregnant rat.
    Sagrillo CA; Voogt JL
    Endocrinology; 1991 Aug; 129(2):925-30. PubMed ID: 1906806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bicuculline infusions advance the timing of luteinizing hormone surge in proestrous rats: comparisons with naloxone effects.
    Kimura F; Jinnai K
    Horm Behav; 1994 Dec; 28(4):424-30. PubMed ID: 7729810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opioid inhibition of luteinizing hormone release declines with age and acyclicity in female rats.
    Field E; Kuhn CM
    Endocrinology; 1988 Dec; 123(6):2626-31. PubMed ID: 3197639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Noradrenergic and endogenous opioid pathways in the regulation of luteinizing hormone secretion in the male rat.
    Miller MA; Clifton DK; Steiner RA
    Endocrinology; 1985 Aug; 117(2):544-8. PubMed ID: 4017946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simulation of the proestrous luteinizing hormone (LH) surge after infusion of LH-releasing hormone in phenobarbital-blocked rats.
    Blake CA
    Endocrinology; 1976 Feb; 98(2):451-60. PubMed ID: 765122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of naloxone on luteinizing hormone, follicle-stimulating hormone, and prolactin secretion in the different phases of the estrous cycle.
    Piva F; Maggi R; Limonta P; Motta M; Martini L
    Endocrinology; 1985 Aug; 117(2):766-72. PubMed ID: 3926461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of endogenous opioid peptides in the initiation of the midcycle luteinizing hormone surge in normal cycling women.
    Rossmanith WG; Mortola JF; Yen SS
    J Clin Endocrinol Metab; 1988 Oct; 67(4):695-700. PubMed ID: 3138276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of galanin in stimulation of pituitary luteinizing hormone secretion as revealed by a specific receptor antagonist, galantide.
    Sahu A; Xu B; Kalra SP
    Endocrinology; 1994 Feb; 134(2):529-36. PubMed ID: 7507825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A possible dual mechanism involved in the inhibitory influence of suckling on luteinizing hormone release in the ovariectomized rat.
    Wu TJ; McArthur NH; Harms PG
    Biol Reprod; 1992 Apr; 46(4):653-7. PubMed ID: 1576262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence that long-term estrogen treatment disrupts opioid involvement in the induction of pituitary LH surge.
    Fuentes M; Sahu A; Kalra SP
    Brain Res; 1992 Jun; 583(1-2):183-8. PubMed ID: 1504826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential regulation of preovulatory luteinizing hormone and follicle-stimulating hormone release by opioids in the proestrous rat.
    Kumru S; Simşek M; Yilmaz B; Sapmaz E; Kutlu S; Sandal S; Canpolat S
    Physiol Res; 2001; 50(4):397-403. PubMed ID: 11551146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.